miltefosine has been researched along with Neglected Diseases in 7 studies
miltefosine: hexadecyl phosphocholine derivative of cisplatin; did not substantially activate HIV long terminal repeat; less toxic than cisplatin
miltefosine : A phospholipid that is the hexadecyl monoester of phosphocholine.
Neglected Diseases: Diseases that are underfunded and have low name recognition but are major burdens in less developed countries. The World Health Organization has designated six tropical infectious diseases as being neglected in industrialized countries that are endemic in many developing countries (HELMINTHIASIS; LEPROSY; LYMPHATIC FILARIASIS; ONCHOCERCIASIS; SCHISTOSOMIASIS; and TRACHOMA).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Visceral leishmaniasis is a serious public health problem on the Indian subcontinent, causing high morbidity and mortality." | 2.53 | Elimination of visceral leishmaniasis on the Indian subcontinent. ( Boelaert, M; Hasker, E; Singh, OP; Sundar, S, 2016) |
| "Visceral leishmaniasis is a neglected parasitic disease that has a high fatality rate in the absence of treatment." | 1.42 | SAR refinement of antileishmanial N(2),N(4)-disubstituted quinazoline-2,4-diamines. ( Barber, MM; Manetsch, R; Van Horn, KS; Wang, MZ; Werbovetz, KA; Yang, S; Zhu, X, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhu, X | 1 |
| Van Horn, KS | 1 |
| Barber, MM | 1 |
| Yang, S | 1 |
| Wang, MZ | 1 |
| Manetsch, R | 1 |
| Werbovetz, KA | 1 |
| Rijal, S | 1 |
| Sundar, S | 2 |
| Mondal, D | 1 |
| Das, P | 1 |
| Alvar, J | 1 |
| Boelaert, M | 2 |
| Doshi, P | 1 |
| Kesselheim, AS | 1 |
| Maggs, LR | 1 |
| Sarpatwari, A | 1 |
| Mukhopadhyay, D | 1 |
| Mukherjee, S | 1 |
| Ghosh, S | 1 |
| Roy, S | 1 |
| Saha, B | 1 |
| Das, NK | 1 |
| Chatterjee, M | 1 |
| Singh, OP | 1 |
| Hasker, E | 1 |
| Dorlo, TP | 1 |
| Eggelte, TA | 1 |
| Schoone, GJ | 1 |
| de Vries, PJ | 1 |
| Beijnen, JH | 1 |
1 review available for miltefosine and Neglected Diseases
| Article | Year |
|---|---|
Elimination of visceral leishmaniasis on the Indian subcontinent.
Topics: Amphotericin B; Animals; Antiprotozoal Agents; Health Services Accessibility; Humans; India; Insect | 2016 |
6 other studies available for miltefosine and Neglected Diseases
| Article | Year |
|---|---|
SAR refinement of antileishmanial N(2),N(4)-disubstituted quinazoline-2,4-diamines.
Topics: Animals; Antiprotozoal Agents; Diamines; Humans; Leishmania donovani; Leishmaniasis, Visceral; Mice; | 2015 |
Eliminating visceral leishmaniasis in South Asia: the road ahead.
Topics: Amphotericin B; Animals; Antiprotozoal Agents; Bangladesh; Disease Vectors; Drug Therapy, Combinatio | 2019 |
US incentive scheme for neglected diseases: a good idea gone wrong?
Topics: Antiprotozoal Agents; Drug Approval; Drug Industry; Health Policy; Humans; Neglected Diseases; Orpha | 2014 |
Experience With the Priority Review Voucher Program for Drug Development.
Topics: Antibodies, Monoclonal; Antimalarials; Antineoplastic Agents; Antiprotozoal Agents; Antitubercular A | 2015 |
A male preponderance in patients with Indian post kala-azar dermal leishmaniasis is associated with increased circulating levels of testosterone.
Topics: Adolescent; Adult; Amphotericin B; Antibodies, Protozoan; Antimony Sodium Gluconate; Antiprotozoal A | 2016 |
A poor-quality generic drug for the treatment of visceral leishmaniasis: a case report and appeal.
Topics: Antiprotozoal Agents; Bangladesh; Drugs, Generic; Humans; Leishmaniasis, Visceral; Neglected Disease | 2012 |